	Geographic Variability in Germline Genetic Testing for Prostate Cancer: A Nationwide Medicare Claims Study With Evidence of Low Uptake. J Natl Compr Canc Netw Korn SM, Qian Z, Zurl H, Piccolini A, Pohl KK, Lipsitz SR, Zhang J, Kibel AS, Moore CM, Rana HQ, Kilbridge KL, Shariat SF, Giri VN, Loeb S, Trinh QD, Cole AP. PMID: 41671443 [PubMed - indexed for MEDLINE]
	A Prospective Validation of the Decipher Genomic Classifier in Men With Early Localized Prostate Cancer: The VANDAAM Study. J Natl Compr Canc Netw Yamoah K, Trivedi P, Awasthi S, Grass GD, Torres-Roca J, Johnstone PA, Dhillon J, Park JY, Davicioni E, Hakansson A, Liu Y, Fink AK, Katende E, Smith R, Putney R, Poch M, Li R, Manley B, Fernandez D, Gage K, Ferguson K, Lu-Yao G, Kim Y, Katsoulakis E, Leone A, Vapiwala N, Deville C, Rebbeck TR, Dicker AP, Kelly W, Yin V, Burri RJ, Ercole CE, Pow-Sang J. PMID: 41671436 [PubMed - indexed for MEDLINE]
	Prostate cancer survival according to socioeconomic and tumor characteristics in Manizales, Colombia. Rev Peru Med Exp Salud Publica Giraldo-Osorio A, Ladino JD, Giraldo Restrepo MÁ, Vargas Dussan LF, Arias-Ortiz N. PMID: 41670103 [PubMed - indexed for MEDLINE]
	Evolving strategies in prostate cancer: Emerging approaches and unmet needs from the Bridging the Gaps in Prostate Cancer expert panel. Cancer McKay RR, Maughan BL, Morgans AK, Shore ND, Yu EY, Madan RA, Berchuck JE, Carthon BC, Finkelstein SE, Gomella L, Gorin MA, Hahn AW, Loeb S, Narayan VK, Petrylak DP, Ryan CJ, Tawagi K, Tran PT, Dorff T. PMID: 41669866 [PubMed - indexed for MEDLINE]
	Clinical application of PRIMARY score in diagnosing clinically significant prostate cancer: a comparative study using (68)Ga-PSMA-11 and (18)F-PSMA-1007 positron emission tomography/computed tomography. Quant Imaging Med Surg Xie YJ, Zou Q, Yang T, Hu SQ, Shen ZJ, Chen GF, Li S, Zhang Y. PMID: 41669446 [PubMed]
	Revealing the function and mechanism of piRNA-related genes in bladder cancer through single-cell sequencing and methylation analyses and construction of prognostic features based on consensus clustering. Curr Urol Sun X, Jia D, Song X, Jiang Y, Wu F, Ning H, Lyu J. PMID: 41668898 [PubMed]
	Significant differences in CD276 (B7H3) expression between female and male bladder cancer tissue samples: An exploratory study. Curr Urol Harland N, Reitnauer LE, Amend B, Bahlinger V, Hennenlotter J, Stenzl A, Aicher WK, Walz S. PMID: 41668895 [PubMed]
	Anxiety, Depression, and Suicidality Among Testicular Cancer Survivors. Cancer Med Meagher M, Riviere P, Nelson T, Morgan K, Puri D, Pandit K, Yodkhunnatham N, Yuen K, Taylor J, Herchenhorn D, Stewart T, Javier-Desloges J, Salmasi A, McKay R, Kern S, Millard F, Rose B, Bagrodia A. PMID: 41668134 [PubMed - indexed for MEDLINE]
	Predicting renal-cell carcinoma recurrence after partial nephrectomy: a CT-radiomics approach. Int Urol Nephrol Vovdenko S, Kuznetsov I, Amrakhov S, Chernenkiy M, Chernenkiy I, Proskura A, Zholdubaev A, Ismailov K, Vinogradov A, Fiev D, Sirota E, Shpot E, Alyaev Y, Glybochko P. PMID: 41667901 [PubMed - as supplied by publisher]
	Treatment patterns in patients with castration-resistant prostate cancer who received darolutamide in the ARAMIS trial in Spain: PARASEC study. Clin Transl Oncol Puente J, Campanario R, Marmolejo D, Cantero-Mellado JA, Gómez-Ferrer Á, Rodríguez Antolín A, Ribal MJ, Picola Brau N, Ledo MJ, Hernandez C, Llorente C, González-Enguita C, Bisonó Castillo Á, Benejam J, Gil Guijarro J, Garcia-Sanchez J, Folqué J, Casas-Nebra J. PMID: 41667886 [PubMed - as supplied by publisher]
	Transperineal Versus Transrectal Biopsy for Prostate Cancer Diagnosis: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Eur Urol Oncol Marra G, Bazzurro F, Dematteis A, Sasia A, Gardois P, Venturi A, Merani U, Calleris G, Marquis A, Oderda M, Matsukawa A, Zugna D, Shariat SF, Ploussard G, Briganti A, Gandaglia G, Rajwa P, Richiardi L, Gontero P. PMID: 41667335 [PubMed - as supplied by publisher]
	Initial Experience With Robot-Assisted Nephroureterectomy Using the Hugo Robot-Assisted Surgery System via a Retroperitoneal Approach: Clinical Comparison With the Transperitoneal Approach. Asian J Endosc Surg Morizane S, Yamamoto A, Yamane H, Nishikawa R, Kimura Y, Yamaguchi N, Hikita K, Ikeda M, Tabata KI, Mukuda T, Kaidoh T, Takenaka A. PMID: 41666941 [PubMed - indexed for MEDLINE]
	Not all PI-RADS 3 lesions are the same: Higher rate of clinically significant prostate cancer among Black men on targeted biopsy in a diverse cohort. Urol Oncol Hanelin DG, Dave P, Baca A, Joseph M, Patel R, Sankin A, Aboumohamed A, Reese S, Agalliu I, Watts K. PMID: 41666650 [PubMed - as supplied by publisher]
	Combination of serum TBL1XR1, MFAP5, and PSA as diagnostic biomarkers for prostate cancer. Clinics (Sao Paulo) Wu X, Lin X, Lin J. PMID: 41666500 [PubMed - as supplied by publisher]
	Systematic assessment of obesity-related risk factors in renal cancer etiology: A longitudinal risk and mendelian randomization analysis. PLoS Med Alcala K, Mariosa D, Jacobson S, Coscia-Requena C, Dimou N, Franklin O, Martin RM, Smith GD, Gunter MJ, Brennan P, Pollak M, Langdon R, Johansson M. PMID: 41666231 [PubMed - as supplied by publisher]
	Renal and urothelial cancer risks with SGLT2 inhibitors vs GLP-1 receptor agonists in type 2 diabetes: a target trial emulation. Nephrol Dial Transplant Huang CW, Lai EC, Wu VC, Hsieh MH, Li CJ, Chang R, Chen JS, Tsai YS, Sung JM. PMID: 41665869 [PubMed - as supplied by publisher]
	ASO Practice Guidelines Series: Surgical Management of Bladder Cancer Relapse. Ann Surg Oncol Aydogdu C, McSweeney ST, Packiam VT, Bukavina L. PMID: 41665782 [PubMed - as supplied by publisher]
	Impact of radium-223 on bone imaging and biochemical markers with and without bone-modifying agents in bone-metastatic castration-resistant prostate cancer: results from the kyucog-1901 study. Eur J Nucl Med Mol Imaging Shiota M, Enokida H, Murakami Y, Kamoto T, Igawa T, Masumori N, Uemura H, Mitsunari K, Sumiyoshi T, Uemura H, Higashijima K, Tokunaga S, Isoda T, Ishigami K, Eto M. PMID: 41665676 [PubMed - as supplied by publisher]
	Treatment planning parameters in intensity modulated radiotherapy for prostate cancer and their dosimetric impact: a study using Monaco TPS. Radiat Environ Biophys Coc FL, Marcu LG. PMID: 41665669 [PubMed - as supplied by publisher]
	Generation of 3D reference dosimetric datasets towards adoption of model-based dose calculations for permanent implant prostate brachytherapy. Med Phys Akbari F, Peppa V, Ouellet S, Moghadam N, Oliver S, Gimenez-Alventosa V, Beaulieu L, Vijande J, Thomson RM. PMID: 41665530 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 175909

Page 1 of 8796



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy